B cell-ablative therapy for the treatment of autoimmune diseases.
Publication
, Journal Article
Patel, DD
Published in: Arthritis Rheum
August 2002
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Arthritis Rheum
DOI
ISSN
0004-3591
Publication Date
August 2002
Volume
46
Issue
8
Start / End Page
1984 / 1985
Location
United States
Related Subject Headings
- Immunosuppression Therapy
- Humans
- Cytotoxicity, Immunologic
- B-Lymphocytes
- Autoimmune Diseases
- Arthritis, Rheumatoid
- Arthritis & Rheumatology
- Antigens, CD20
- Antibodies, Monoclonal
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, D. D. (2002). B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis Rheum, 46(8), 1984–1985. https://doi.org/10.1002/art.10476
Patel, Dhavalkumar D. “B cell-ablative therapy for the treatment of autoimmune diseases.” Arthritis Rheum 46, no. 8 (August 2002): 1984–85. https://doi.org/10.1002/art.10476.
Patel DD. B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis Rheum. 2002 Aug;46(8):1984–5.
Patel, Dhavalkumar D. “B cell-ablative therapy for the treatment of autoimmune diseases.” Arthritis Rheum, vol. 46, no. 8, Aug. 2002, pp. 1984–85. Pubmed, doi:10.1002/art.10476.
Patel DD. B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis Rheum. 2002 Aug;46(8):1984–1985.
Published In
Arthritis Rheum
DOI
ISSN
0004-3591
Publication Date
August 2002
Volume
46
Issue
8
Start / End Page
1984 / 1985
Location
United States
Related Subject Headings
- Immunosuppression Therapy
- Humans
- Cytotoxicity, Immunologic
- B-Lymphocytes
- Autoimmune Diseases
- Arthritis, Rheumatoid
- Arthritis & Rheumatology
- Antigens, CD20
- Antibodies, Monoclonal
- 1117 Public Health and Health Services